India Share Brokers | Equity Trading India | Derivative Trading in India | Share Brokers in India

Markets Navigation

Company Info.

Neuland Laboratories Ltd.

Income Statement - Consolidated

Market Cap.(`)	21437.85 Cr.	P/BV	16.72	Book Value (`)	999.07
52 Week High/Low ( ` )	16878/4926	FV/ML	10/1	P/E(X)	71.44
Book Closure	15/07/2024	EPS (`)	233.89	Div Yield (%)	0.08

(` in Crs.)

You can view the Consolidated Income Statement for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	1515.66	1160.90	923.33	918.18	734.45
Other Operating Revenues	42.92	30.30	27.74	18.74	28.26
Total Operating Revenues	1558.58	1191.20	951.08	936.91	762.71

Other Income	12.54	9.75	2.08	16.10	3.89
Total Revenue	1571.12	1200.95	953.15	953.01	766.60

EXPENSES
Cost Of Materials Consumed	632.43	487.74	437.55	439.66	391.36
Operating And Direct Expenses	156.51	135.56	131.36	120.29	97.60
Changes In Inventories Of FG,WIP And Stock-In Trade	-55.14	-9.51	-15.41	-1.24	-11.16
Employee Benefit Expenses	257.06	201.79	182.47	149.74	123.56
Finance Costs	14.00	13.07	13.50	17.90	21.57
Depreciation And Amortisation Expenses	59.70	52.78	49.04	39.68	31.28
Other Expenses	105.13	103.78	72.48	81.66	59.47
Total Expenses	1169.69	985.20	870.99	847.67	713.67

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	401.44	215.75	82.16	105.33	52.92

Profit/Loss Before Tax	401.44	215.75	82.16	105.33	52.92

Tax Expenses-Continued Operations
Current Tax	99.67	50.44	20.43	12.56	0.10
Deferred Tax	1.69	1.79	-2.09	12.15	36.62
Total Tax Expenses	101.36	52.23	18.34	24.70	36.71
Profit/Loss After Tax And Before ExtraOrdinary Items	300.08	163.52	63.82	80.63	16.21

Profit/Loss From Continuing Operations	300.08	163.52	63.82	80.63	16.21

Profit/Loss For The Period	300.08	163.52	63.82	80.63	16.21
Consolidated Profit/Loss After MI And Associates	300.08	163.52	63.82	80.63	16.21

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	233.89	127.45	49.74	62.85	12.63
Diluted EPS (Rs.)	233.89	127.45	49.74	62.85	12.63

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	12.83	6.41	3.85	2.57	4.95

Neuland Laboratories Ltd.

Balance Sheet - Consolidated

Market Cap.(`)	21437.85 Cr.	P/BV	16.72	Book Value (`)	999.07
52 Week High/Low ( ` )	16878/4926	FV/ML	10/1	P/E(X)	71.44
Book Closure	15/07/2024	EPS (`)	233.89	Div Yield (%)	0.08

(` in Crs.)

You can view the Consolidated Balance Sheet for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	128.30	128.30	128.30	128.30	128.30

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	12.90	12.90	12.90	12.90	12.90
Total Share Capital	12.90	12.90	12.90	12.90	12.90

Revaluation Reserves	0.84	0.84	0.84	0.84	0.84
Reserves and Surplus	1268.97	980.36	826.76	772.72	696.22
Total Reserves and Surplus	1269.80	981.20	827.60	773.56	697.06
Total Shareholders Funds	1282.70	994.10	840.50	786.46	709.96

NON-CURRENT LIABILITIES
Long Term Borrowings	44.92	74.25	104.25	88.13	77.37
Deferred Tax Liabilities [Net]	60.44	58.30	56.70	59.76	47.78
Other Long Term Liabilities	9.20	3.88	6.97	12.49	25.74
Long Term Provisions	7.61	10.29	11.91	9.44	12.49
Total Non-Current Liabilities	122.17	146.71	179.83	169.82	163.39

CURRENT LIABILITIES
Short Term Borrowings	37.59	47.26	126.70	56.98	168.17
Trade Payables	191.96	171.01	112.27	152.13	115.56
Other Current Liabilities	196.50	219.16	122.98	158.75	71.63
Short Term Provisions	1.64	1.53	1.21	0.64	2.27
Total Current Liabilities	427.68	438.96	363.16	368.51	357.63

Total Capital And Liabilities	1832.56	1579.76	1383.49	1324.79	1230.98

ASSETS
NON-CURRENT ASSETS
Tangible Assets	541.75	476.78	485.78	432.88	371.15
Intangible Assets	2.46	1.30	2.12	3.50	1.96
Capital Work-In-Progress	45.89	40.57	20.46	17.25	23.75
Fixed Assets	590.10	518.64	508.35	453.63	396.86
Goodwill On Consolidation	279.46	279.46	279.46	279.46	279.46
Non-Current Investments	1.28	0.52	0.50	0.44	0.36
Other Non-Current Assets	40.64	20.24	12.40	41.67	39.11
Total Non-Current Assets	911.48	818.87	800.71	775.20	715.79


CURRENT ASSETS
Current Investments	0.00	0.00	3.38	6.46	7.50
Inventories	350.42	279.23	265.21	247.61	219.55
Trade Receivables	373.53	361.77	234.33	217.73	189.89
Cash And Cash Equivalents	116.80	59.10	20.36	19.40	46.98
OtherCurrentAssets	80.34	60.79	59.50	58.39	51.27
Total Current Assets	921.08	760.89	582.78	549.59	515.19

Total Assets	1832.56	1579.76	1383.49	1324.79	1230.98

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	140.47	100.72	92.99	127.52	134.68

BONUS DETAILS
Bonus Equity Share Capital	0.72	0.72	0.72	0.72	0.72

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	1.28	0.25	0.25	0.25	0.25

CURRENT INVESTMENTS
Current Investments Unquoted Book Value	0.00	0.00	3.38	6.46	7.50

Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. | | ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors" | ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600 | For any Grievance mail to : [email protected] | For any DP Grievance mail to : [email protected]. | Grievance with SEBI : https://scores.gov.in/scores/Welcome.html

Share Wealth

Neuland Laboratories Ltd.

Income Statement - Consolidated

Neuland Laboratories Ltd.

Balance Sheet - Consolidated